Vaxxas, a clinical-stage biotechnology company, has expanded its global intellectual property portfolio to 42 patents, supporting its exclusive claim ...
UC Santa Barbara researchers and their colleagues estimate that without intervention, plastic pollution is on track to double by 2050. But in a study ...